Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

Date: May 19, 2017

PMJAY India public health

With a view to achieve the objective of making available quality generic medicines at affordable prices to all, ‘Jan Aushadhi Scheme’ was launched by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India in November, 2008 across the country. The Scheme is being implemented through the Bureau of Pharma PSUs of India (BPPI), under administrative control of Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India.

Ø In September 2015, the ‘Jan Aushadhi Scheme’ was revamped as ‘Pradhan Mantri Jan Aushadhi Yojana’ (PMJAY). In November, 2016, to give further impetus to the scheme, it was again renamed as “Pradhan Mantri Bhartiya Janaushadhi Pariyojana” (PMBJP). The Hon'ble Minister of Finance while presenting the Budget for the year 2016-17 in Parliament, made a special mention on PMJAY.


Ø Salient features of the scheme:

Ensure access to quality medicines
Extend coverage of quality generic medicines so as to reduce the out of pocket expenditure on medicines and thereby redefine the unit cost of treatment per person
Create awareness about generic medicines through education and publicity so that quality is not synonymous with only high price
A public programme involving Government, PSUs, Private Sector, NGO, Societies, Co-operative Bodies and other Institutions
Create demand for generic medicines by improving access to better healthcare through low treatment cost and easy availability wherever needed in all therapeutic categories.

Ø Quality assurance: To ensure high quality, medicines are procured from WHO Good manufacturing practice (GMP), Current Good Manufacturing Practice (USFDA) and CPSUs manufacturers for supplying to Pradhan Mantri Bhartiya Janaushadhi Kendras. Each batch of drugs procured is tested random at BPPI’s empanelled National Accreditation Board for Testing and Calibration Laboratories (NABL) accredited laboratories thereby ensuring quality, safety and efficacy of medicines and conformance with required standards. Only after being certified by these laboratories, medicines are dispatched to C&F agents, Distributors and JAKs.

Ø Likely Impact: PMBJP seeks to keep product price within 50% of branded product price to make it affordable for all, especially the poor. It has resulted in substantial amount of savings for the people.